After controlling for confounding variables (sex, age, body mass index, arterial hypertension, statin dose and PCSK9 inhibitor dose), all correlations were still significant except the association between change in GlycB and change in triglycerides (Figure 2). Here, PCSK9 is linked to Hypertension.